Some reports have suggested that postoperative irradiation increases the risk of CDKN2A homozygous deletion, which is frequently observed in recurrent grade 4 IDH-mutant astrocytomas and is associated with increased cellular proliferation [44,45]. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).